Insider · CIK 0001602474
Dalal Anupam
Reports to the SEC for 3 companies · MORRISTOWN, NJ
Transactions
21
Companies
3
Filings
17
CIK
0001602474
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-12 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-05-14 | WHWKWhitehawk Therapeutics, Inc.A Award | +$5M |
| 2025-06-12 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-03-04 | WHWKWhitehawk Therapeutics, Inc.A Award | +$3.75M |
| 2024-06-12 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-15 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-09-26 | WHWKWhitehawk Therapeutics, Inc.A Award | +$4M |
| 2022-06-15 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-08-27 | WHWKWhitehawk Therapeutics, Inc. · Stock option (right to buy)A Award | — |
| 2021-08-26 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$20M |
| 2021-08-26 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$20M |
| 2021-06-30 | WHWKWhitehawk Therapeutics, Inc.A Award | +$11.2K |
| 2021-03-31 | WHWKWhitehawk Therapeutics, Inc.A Award | +$11.2K |
| 2021-02-01 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-24 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-06-18 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-06-20 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-12-22 | WHWKWhitehawk Therapeutics, Inc.J Other | — |
| 2017-12-22 | WHWKWhitehawk Therapeutics, Inc.J Other | — |
| 2016-06-16 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2015-06-10 | AKBAAkebia Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Dalal Anupam0001602474-26-000004SEC(opens sec.gov)
- 4Dalal Anupam0001415889-25-017407SEC(opens sec.gov)
- 4Dalal Anupam0001415889-25-007096SEC(opens sec.gov)
- 4Dalal Anupam0001415889-24-016865SEC(opens sec.gov)
- 4Dalal Anupam0001209191-23-038662SEC(opens sec.gov)
- 4Dalal Anupam0001209191-22-051390SEC(opens sec.gov)
- 4Dalal Anupam0001209191-22-037874SEC(opens sec.gov)
- 4/ADalal Anupam0000899243-21-034635SEC(opens sec.gov)
- 4Dalal Anupam0000899243-21-034546SEC(opens sec.gov)
- 4Dalal Anupam0000899243-21-027291SEC(opens sec.gov)
- 4Dalal Anupam0000899243-21-014675SEC(opens sec.gov)
- 4Dalal Anupam0000899243-21-004890SEC(opens sec.gov)
- 4Dalal Anupam0000899243-20-017776SEC(opens sec.gov)
- 4Dalal Anupam0000899243-19-017445SEC(opens sec.gov)
- 4Dalal Anupam0000899243-18-017756SEC(opens sec.gov)
- 5Dalal Anupam0000899243-18-003896SEC(opens sec.gov)
- 4Akebia Therapeutics, Inc.0001562180-16-002661SEC(opens sec.gov)
Companies
Address
C/O WHITEHAWK THERAPEUTICS, INC. 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T
MORRISTOWN, NJ, 07960